NKT cell ligand-induced cytokines enhance antitumor effects with PD-1 blockade by reinvigorating exhausted CD8 T cells

被引：0
|
作者：
Bae, Eun-ah [1 ]
Seo, Hyungseok [1 ]
Choi, Jeongwon [1 ]
Lee, Jeongmi [1 ]
Kang, Chang-Yuil [1 ]
机构：
[1] Seoul Natl Univ, Seoul, South Korea
来源：
JOURNAL OF IMMUNOLOGY | 2018年 / 200卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
122.18
引用
收藏
页数：3
相关论文
共 50 条
  • [31] PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1+CD38hi cells and anti-PD-1 resistance
    Verma, Vivek
    Shrimalim, Rajeev K.
    Ahmadm, Shamim
    Dai, Winjie
    Wang, Hua
    Lu, Sumin
    Nandrelm, Rahul
    Gaur, Pankaj
    Lopez, Jose
    Sade-Feldman, Moshe
    Yizhak, Keren
    Bjorgaard, Stacey L.
    Flaherty, Keith T.
    Wargo, Jennifer A.
    Boland, Genevieve M.
    Sullivan, Ryan J.
    Getz, Gad
    Hammond, Scott A.
    Tan, Ming
    Qi, Jingjing
    Wong, Phillip
    Merghoub, Taha
    Wolchok, Jedd
    Hacohen, Nir
    Janik, John E.
    Mkrtichyan, Mikayel
    Gupta, Seema
    Khleif, Samir N.
    NATURE IMMUNOLOGY, 2019, 20 (09) : 1231 - +
  • [32] Blockade of PD-1 and LAG-3 expression on CD8+T cells promotes the tumoricidal effects of CD8+T cells
    Ma, Jiajia
    Yan, Shufang
    Zhao, Ying
    Yan, Huifang
    Zhang, Qian
    Li, Xinxia
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [33] PD-1 expression on dendritic cells suppresses CD8+ T cell function and antitumor immunity
    Lim, Tong Seng
    Chew, Valerie
    Sieow, Je Lin
    Goh, Siting
    Yeong, Joe Poh-Sheng
    Soon, Ai Ling
    Ricciardi-Castagnoli, Paola
    ONCOIMMUNOLOGY, 2016, 5 (03):
  • [34] Infiltration of CD8 T Cells and Expression of PD-1 and PD-L1 in Synovial Sarcoma
    Nowicki, Theodore S.
    Akiyama, Ryan
    Huang, Rong Rong
    Shintaku, I. Peter
    Wang, Xiaoyan
    Tumeh, Paul C.
    Singh, Arun
    Chmielowski, Bartosz
    Denny, Christopher
    Federman, Noah
    Ribas, Antoni
    CANCER IMMUNOLOGY RESEARCH, 2017, 5 (02) : 118 - 126
  • [35] Circulating cancer-specific CD8 T cell frequency is associated with response to PD-1 blockade in Merkel cell carcinoma
    Pulliam, Thomas
    Jani, Saumya
    Jing, Lichen
    Ryu, Heeju
    Jojic, Ana
    Shasha, Carolyn
    Zhang, Jiajia
    Kulikauskas, Rima
    Church, Candice
    Garnett-Benson, Charlie
    Gooley, Ted
    Chapuis, Aude
    Paulson, Kelly
    Smith, Kellie N.
    Pardoll, Drew M.
    Newell, Evan W.
    Koelle, David M.
    Topalian, Suzanne L.
    Nghiem, Paul
    CELL REPORTS MEDICINE, 2024, 5 (02)
  • [36] Rescue of exhausted CD8 T cells by PD-1-targeted therapies is CD28-dependent
    Kamphorst, Alice O.
    Wieland, Andreas
    Nasti, Tahseen
    Yang, Shu
    Zhang, Ruan
    Barber, Daniel L.
    Konieczny, Bogumila T.
    Daugherty, Candace Z.
    Koenig, Lydia
    Yu, Ke
    Sica, Gabriel L.
    Sharpe, Arlene H.
    Freeman, Gordon J.
    Blazar, Bruce R.
    Turka, Laurence A.
    Owonikoko, Taofeek K.
    Pillai, Rathi N.
    Ramalingam, Suresh S.
    Araki, Koichi
    Ahmed, Rafi
    SCIENCE, 2017, 355 (6332) : 1423 - 1427
  • [37] NEOADJUVANT PD-1 ANTIBODY BLOCKADE IS ASSOCIATED WITH FOCAL UPREGULATION OF PD-L1 AND CD8 T CELL INFILTRATE IN RECURRENT GLIOBLASTOMA
    Orpilla, Joey
    Mochizuki, Aaron
    Reynoso, Jeremy
    Akkad, Neha
    Lee, Alexander
    Davidson, Tom
    Liau, Linda
    Cloughesy, Timothy
    Prins, Robert
    NEURO-ONCOLOGY, 2018, 20 : 6 - 6
  • [38] PD-1 blockade potentiates neoadjuvant chemotherapy in NSCLC via increasing CD127+ and KLRG1+ CD8 T cells
    Hui, Zhenzhen
    Ren, Yulin
    Zhang, Dong
    Chen, Yulong
    Yu, Wenwen
    Cao, Jie
    Liu, Liang
    Wang, Tao
    Xiao, Shanshan
    Zheng, Liuqing
    Pu, Yue
    Wei, Feng
    You, Jian
    Ren, Xiubao
    NPJ PRECISION ONCOLOGY, 2023, 7 (01)
  • [39] PD-1 blockade therapy augments the antitumor effects of lymphodepletion and adoptive T cell transfer
    Takahashi, Miho
    Watanabe, Satoshi
    Suzuki, Ryo
    Arita, Masashi
    Sato, Ko
    Sato, Miyuki
    Sekiya, Yuki
    Abe, Yuko
    Fujisaki, Toshiya
    Ohtsubo, Aya
    Shoji, Satoshi
    Nozaki, Koichiro
    Ichikawa, Kosuke
    Kondo, Rie
    Saida, Yu
    Hokari, Satoshi
    Aoki, Nobumasa
    Hayashi, Masachika
    Ohshima, Yasuyoshi
    Koya, Toshiyuki
    Kikuchi, Toshiaki
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (06) : 1357 - 1369
  • [40] PD-1 blockade potentiates neoadjuvant chemotherapy in NSCLC via increasing CD127+ and KLRG1+ CD8 T cells
    Zhenzhen Hui
    Yulin Ren
    Dong Zhang
    Yulong Chen
    Wenwen Yu
    Jie Cao
    Liang Liu
    Tao Wang
    Shanshan Xiao
    Liuqing Zheng
    Yue Pu
    Feng Wei
    Jian You
    Xiubao Ren
    npj Precision Oncology, 7
12345